5.1 Type 1 and Type 2 Diabetes: Inpatient Glycaemic Control, DKA, and HHS
Key Takeaways
Adult DKA requires diabetes or hyperglycaemia, ketosis and metabolic acidosis. IAEM and the international consensus use different numeric thresholds. Near-normal glucose can occur with DKA. In metabolic acidosis, a measured arterial carbon dioxide outside the expected response suggests a second acid–base process.
In adult DKA restore perfusion, check potassium before starting insulin and track blood ketones and acid–base recovery. Add glucose as needed to allow ongoing ketone clearance.
HHS management starts with fluid assessment and close osmolality monitoring. Distinguish effective from total osmolality and follow the relevant pathway for insulin and mixed DKA/HHS.
Use the HSE paediatric DKA pathway for children and the HSE adult pathway for hypoglycaemia. Distinguish oral glucose when swallowing is safe from urgent parenteral treatment when it is not.
Protect basal insulin coverage in type 1 diabetes and make an individual perioperative medication plan, including the SGLT2 inhibitor interruption and blood ketone assessment when indicated.
Recognising Adult Diabetic Ketoacidosis
Insulin deficiency and increased counter-regulatory hormones promote hepatic glucose production and reduce peripheral glucose uptake. Hyperglycaemia can lead to osmotic diuresis with volume and electrolyte loss. Insulin deficiency also promotes lipolysis. The liver converts fatty acids into ketone bodies including acetoacetate and beta-hydroxybutyrate, generating a metabolic acidosis. DKA can occur in type 1 or type 2 diabetes or be the first presentation. Vomiting, abdominal pain, dehydration, deep breathing or reduced alertness should trigger early blood glucose, blood ketones and venous gas testing.
Match the Thresholds to the Guideline
| Component | IAEM adult ED guideline, January 2026 | International adult consensus, 2024 |
|---|---|---|
| Diabetes or raised glucose | Known diabetes or glucose >11 mmol/L | Known diabetes or glucose ≥11.1 mmol/L |
| Ketosis | Blood ketones >3 mmol/L or urine ketones >2+ | Beta-hydroxybutyrate ≥3 mmol/L or urine ketones ≥2+ |
| Acidosis | Venous pH <7.30 or bicarbonate <15 mmol/L | pH <7.30 or bicarbonate <18 mmol/L |
All three components are required in each framework. Blood beta-hydroxybutyrate is preferred. Urine dipsticks measure acetoacetate, which may lag behind worsening and recovering ketonaemia. Assess clinical severity and look for infection, interrupted insulin or pump failure, myocardial ischaemia or another precipitant. IAEM critical-care markers include hypotension, marked ketonaemia, profound acidosis, abnormal pulse, hypoxaemia or low potassium at presentation. Use clinical status and the named pathway to decide the level of monitoring.
For a lab that reports the anion gap without potassium, calculate sodium − (chloride + bicarbonate). A high gap can support the diagnosis. If sodium is 136, chloride 100 and bicarbonate 10 mmol/L, the gap without potassium is 26 mmol/L. The IAEM escalation box includes potassium in its formula. Match the result to the reference method. The 2024 consensus prioritises blood ketones and acid–base criteria because hyperchloraemia during treatment can obscure interpretation of the gap.
Check the respiratory response to metabolic acidosis
Review pH, bicarbonate and carbon dioxide together. A pH near 7.40 can conceal two primary disturbances. When there is metabolic acidosis, use Winters' estimate if an arterial gas is available: expected PaCO₂ in mmHg is 1.5 × bicarbonate in mmol/L + 8, with a range of ±2 mmHg. A measured PaCO₂ above the estimate suggests additional respiratory acidosis. A value below it suggests additional respiratory alkalosis. Interpret the estimate with the clinical course and ventilation. It does not use venous PCO₂ and does not replace the venous pH and bicarbonate criteria in the DKA pathway.
For bicarbonate 12 mmol/L the expected PaCO₂ is 26 mmHg (24–28). A PaCO₂ of 40 mmHg in that setting is too high for the expected response, although 40 mmHg can be normal when bicarbonate is normal. Assess for ventilatory impairment as well as the cause of the acidosis.
Albert, Dell and Winters original study · Clinical evaluation in severely ill patients
Euglycaemic DKA
Near-normal glucose can occur with substantial ketosis and acidosis, especially with SGLT2 inhibitor use, perioperative fasting or pregnancy. Check ketones and a venous gas even when the glucose result seems reassuring. Consider starvation or alcohol-related ketoacidosis when the context fits. Stop the implicated SGLT2 inhibitor and use the DKA pathway with early glucose alongside insulin to permit ketone clearance. Avoid restarting the implicated medicine during the acute admission. The Forxiga SmPC advises against restarting after DKA unless another clear precipitant is identified and resolved. Review any subsequent decision with the diabetes team. Pregnancy requires early specialist care and its own pathway.
Treating Adult DKA Safely
- Restore perfusion and assess severity. Obtain IV access, baseline electrolytes, venous pH and blood ketones, and involve senior clinicians. IAEM uses 0.9% sodium chloride. For likely hypovolaemia with systolic blood pressure below 90 mmHg it gives an initial 500 mL over 10–15 minutes with reassessment and escalation. In adults with systolic pressure above 90 mmHg it gives 1 L over 60 minutes as the usual initial plan. Individualise rate and bolus size for cardiac or renal impairment, young adults and frail older adults. Track fluid balance and urine output. The international consensus also accepts balanced isotonic crystalloid.
- Check potassium before starting insulin. A normal serum potassium can coexist with total-body depletion. Insulin, rehydration and correction of acidosis can lower serum potassium rapidly. The 2024 consensus advises monitored replacement and delaying insulin if potassium is below 3.5 mmol/L until it rises above 3.5 mmol/L. The replacement rate is a separate prescription, based on renal function, urine output, IV access, monitoring and local IV potassium policy. Avoid using a potassium-containing bag as a rapid resuscitation bolus. Seek urgent senior advice for markedly low or high values.
- Clear ketones with insulin. IAEM uses a fixed-rate IV insulin infusion, typically 0.1 units/kg/hour once safe, and continues scheduled background long-acting insulin. When glucose falls below 14 mmol/L, IAEM adds 10% glucose at 125 mL/hour alongside saline and advises considering a reduction of insulin to 0.05 units/kg/hour. The adult consensus similarly adds glucose and uses 0.05 units/kg/hour below about 13.9 mmol/L. Use the applicable pathway and monitor ketones. Glucose may normalise before ketosis resolves.
- Reassess response and transition safely. In the IAEM pathway, measure glucose and blood ketones hourly and check pH, potassium and bicarbonate at hours 1, 2, 4 and 6. Check out-of-range potassium hourly and seek senior advice. A ketone fall of about 0.5 mmol/L per hour is a response marker. If response is inadequate, check the infusion, access and underlying cause. Use the protocol's resolution and transition criteria. The international consensus requires blood ketones <0.6 mmol/L and either venous pH ≥7.30 or bicarbonate ≥18 mmol/L. It recommends 1–2 hours of subcutaneous insulin overlap with IV insulin. Avoid relying on the anion gap or urine ketones for resolution. Arrange a safe insulin plan and education before discharge.
Treat the precipitant and review the need for higher-acuity monitoring if perfusion or alertness is impaired. Bicarbonate is reserved for selected cases of extreme acidaemia with senior input. If glucose falls below the safe threshold, treat hypoglycaemia promptly and review the glucose and insulin infusions together.
Children and Young People
Use the Irish HSE paediatric DKA pathway (version 2, effective 28 June 2025). In a child with polyuria, weight loss, vomiting and deep breathing, confirm glucose, ketones and venous acidosis and seek senior paediatric input. Use weight-based fluid and deficit calculations and adjust rescue fluid to perfusion. Under this pathway IV fluids run for at least one hour and shock is reversed before starting IV insulin. The dose is usually 0.1 units/kg/hour, with a lower rate considered in young children according to the pathway. Monitor glucose, ketones, circulation, electrolytes and neurological status. New headache, slowing heart rate or reduced consciousness during treatment warrants emergency assessment for cerebral injury, a glucose check and urgent specific treatment under the paediatric pathway.
Hyperosmolar Hyperglycaemic State
In HHS there is enough insulin action to limit ketogenesis but insufficient action to control blood glucose. Sustained hyperglycaemia causes osmotic diuresis and dehydration. Thirst, reduced access to fluids, impaired cognition and illness may compound the deficit. Onset commonly evolves over days in adults with type 2 diabetes. Look for marked volume depletion, neurological changes and possible triggers such as infection or a vascular event.
Distinguish the Diagnostic Formulas
| Measure | 2024 international consensus and ADA 2026 | JBDS adult HHS |
|---|---|---|
| Glucose | ≥33.3 mmol/L | Usually ≥30 mmol/L |
| Hyperosmolality | Effective >300 mOsm/kg or total >320 mOsm/kg | Total ≥320 mOsm/kg |
| Ketones and acid–base | Blood beta-hydroxybutyrate <3 mmol/L, pH ≥7.30 and bicarbonate ≥15 mmol/L in the diagnostic criteria | No significant ketonaemia, with pH >7.30 and bicarbonate ≥15 mmol/L among typical features. Other causes of mild acidosis can coexist. |
In these formulas, use measured sodium, glucose and urea in mmol/L. Effective osmolality = 2 × sodium + glucose. Total calculated osmolality = 2 × sodium + glucose + urea. For sodium 152, glucose 48 and urea 22.4, effective osmolality is 2 × 152 + 48 = 352 mOsm/kg and total is 374.4 mOsm/kg. Use a consistent formula for serial trends. If hyperosmolality coexists with ketonaemic acidosis, seek senior input for mixed DKA/HHS and a DKA-based insulin regimen.
Restore Circulation, Then Manage the Osmotic Change
- Begin isotonic fluid and reassess promptly. A hypotensive patient needs restoration of perfusion with close reassessment of boluses, especially in frailty, heart failure or kidney impairment. After initial stabilisation, titrate ongoing replacement against urine output, fluid balance, sodium, glucose and osmolality. JBDS targets a fall in osmolality of about 3–8 mOsm/kg/hour. A rise in measured sodium as glucose falls can be expected and is interpreted alongside osmolality and fluid balance.
- Choose insulin timing from the pathway. Under the JBDS approach, in pure HHS without material ketonaemia start with 0.9% sodium chloride. If glucose stops falling after adequate fluid replacement, reassess circulatory volume and renal function and consider IV insulin at 0.05 units/kg/hour. Ketonaemia without acidosis may call for earlier low-dose insulin. Ketonaemic acidosis changes pathway. Monitor potassium and add glucose as indicated while continuing controlled correction.
- Review recovery and complications. Follow neurological state, blood tests and urine output. Assess VTE and bleeding risk and provide prophylaxis if indicated and not contraindicated. Treat the trigger and agree the longer-term diabetes regimen and follow-up.
International hyperglycaemic crises consensus · JBDS HHS guideline
Inpatient Glycaemia, Perioperative Care and Hypoglycaemia
Match insulin to nutrition and acuity. In type 1 diabetes provide basal insulin even when the patient is fasting, using subcutaneous basal or an appropriate IV insulin plan. In non-critical care, ADA 2026 favours basal plus correction when oral intake is poor and basal, mealtime and correction components when the patient is eating. Correction doses can supplement scheduled insulin. Selective correction-only treatment may be used for mild hyperglycaemia in some non-critical patients with type 2 diabetes, with planned review. A reactive regimen alone is unsafe for type 1 diabetes. Review glucose trends, renal function, nutrition and recent hypoglycaemia before changing a dose.
Perioperative Prescribing
Minimise fasting where possible and agree an individual plan. In a patient using insulin, consider the basal formulation, expected missed meals and whether an IV variable-rate regimen with monitored glucose substrate is needed. Agree any basal adjustment in advance. Omit fasting-time sulfonylurea doses under the local plan. The ADA 2026 pathway holds metformin and other oral glucose-lowering agents on the procedure day. Some other perioperative protocols allow metformin in selected circumstances. Use the relevant local policy and product information, considering renal function, contrast and the operation.
- SGLT2 inhibitors: Confirm the agent-specific and local plan. AHA/ACC 2026 uses at least three days for dapagliflozin, empagliflozin and canagliflozin and at least four days for ertugliflozin. The Association of Anaesthetists elective consensus uses the day before and day of the procedure. Irish/EU product information calls for interruption for hospitalised major surgery and blood ketone monitoring. See the perioperative section for restarting and euglycaemic DKA. AHA/ACC 2026 · Association consensus · EMA Forxiga SmPC
Metformin and Iodinated Contrast
Check the formulation and its Irish Summary of Product Characteristics. The example HPRA metformin SmPC lists maximum total daily doses of 2,000 mg at GFR 45–59 and 1,000 mg at GFR 30–44 mL/min, and contraindicates metformin below 30 mL/min. Acute kidney injury, dehydration or tissue hypoxia warrant prompt review because impaired clearance and acute illness increase lactic acidosis risk. The same product information advises withholding before or at intravascular iodinated contrast and restarting no sooner than 48 hours after, once renal function has been reassessed and is stable. Some radiology pathways use AKI, filtration and first-pass renal contrast exposure to decide who needs interruption. Verify the local contrast protocol and product advice before making a plan.
Recognise and Treat Hypoglycaemia
Sweating, tremor and hunger may accompany neuroglycopenic confusion, drowsiness or seizures. Check bedside glucose promptly in a symptomatic person who uses insulin or another drug that can cause hypoglycaemia. The HSE adult acute pathway uses <3.9 mmol/L as its treatment threshold. If alert and safe to swallow, give 15 g of rapid-acting carbohydrate and recheck in 15 minutes. Repeat if still low, then give follow-on carbohydrate according to the HSE pathway and clinical plan. If unable to swallow or unconscious, give nothing orally, assess ABCDE and summon help. Use IV glucose when suitable access is available, or IM glucagon if there is no access, following the applicable protocol. If an insulin infusion is running, follow the hypoglycaemia pathway for stopping, treatment, reassessment and planned restart when still needed. Hypoglycaemia from a sulfonylurea can recur and requires further monitoring. For a child with diabetes who is awake and can swallow, ISPAD gives 0.3 g/kg of fast-acting oral glucose as an example, adjusted to the individual plan and any automated insulin system. Recheck after 15 minutes. Severe episodes or inability to swallow require prompt help and protocol-based parenteral glucose or glucagon, with dose appropriate to age, weight and product.
Prevent the Next Event
Before discharge review why the episode occurred, ability to take treatment, access to supplies and glucose or ketone monitoring, and medication changes. In type 1 diabetes, link insulin education and sick-day advice to a named follow-up team, including during transition from paediatric care. In type 2 diabetes the HSE integrated model coordinates GP, community specialist and hospital care. Review glycaemic control and cardiovascular risk, kidney function and albuminuria, retinal screening and foot care. Individualise medicines and targets to comorbidity and hypoglycaemia risk.
ADA hospital care 2026 · HPRA metformin example · HSE adult hypoglycaemia guideline
A 22-year-old woman with Type 1 diabetes is brought to the emergency department after 2 days of persistent vomiting and abdominal pain. On arrival, she is lethargic with deep, rapid respirations. Observations show blood pressure 94/58 mmHg, heart rate 118 bpm, and respiratory rate 28/min. Laboratory investigations reveal: capillary blood glucose 24.6 mmol/L, capillary beta-hydroxybutyrate 4.8 mmol/L, venous blood gas pH 7.12, serum bicarbonate 8 mmol/L, and serum potassium 3.1 mmol/L. Intravenous access is established. What is the most appropriate immediate medical intervention?
Start isotonic crystalloid, arrange monitored potassium replacement and delay IV insulin until potassium is above 3.5 mmol/L under the adult consensus pathway
Commence a fixed-rate intravenous insulin infusion at 0.1 units/kg/hour immediately alongside 0.9% sodium chloride fluid boluses
Administer an intravenous bolus of 10 units soluble insulin followed by an infusion of 8.4% sodium bicarbonate
Administer 1000 mL of 5% dextrose with 20 mmol potassium chloride over 1 hour to prevent rapid glycaemic drops
A 74-year-old man with a history of Type 2 diabetes and hypertension is transferred from a residential care facility with a 5-day history of increasing confusion, lethargy, and reduced oral intake. Vital signs include blood pressure 88/52 mmHg, pulse 110 bpm, and temperature 37.2°C. Physical examination demonstrates dry mucous membranes and poor skin turgor. Laboratory studies show: blood glucose 48.0 mmol/L, serum sodium 152 mmol/L, serum potassium 4.6 mmol/L, serum urea 22.4 mmol/L, serum creatinine 185 µmol/L, venous pH 7.36, serum bicarbonate 22 mmol/L, and capillary beta-hydroxybutyrate 0.8 mmol/L. The unit uses the JBDS adult HHS pathway. What is the most appropriate initial management strategy?
Administer a rapid intravenous bolus of 0.15 units/kg soluble insulin followed by 0.45% sodium chloride at 1000 mL/hour
Restore perfusion with IV 0.9% sodium chloride and frequent reassessment, then monitor osmolality and initially defer insulin while fluids alone lower glucose
Administer 3% hypertonic saline to correct hypernatraemia slowly alongside high-dose intravenous loop diuretics
Commence a fixed-rate intravenous insulin infusion at 0.1 units/kg/hour and administer 50 mL of 50% dextrose stat
A 58-year-old man with Type 2 diabetes mellitus is admitted for an elective laparoscopic right hemicolectomy scheduled for tomorrow morning at 08:30. His medications include metformin 1000 mg twice daily, gliclazide 80 mg once daily in the morning, and dapagliflozin 10 mg once daily. His baseline eGFR is 52 mL/min/1.73m2. He took dapagliflozin this morning. For dapagliflozin this unit follows the AHA/ACC 2026 interval. For other oral glucose-lowering medicines it follows ADA 2026. What is the most appropriate perioperative instruction regarding his oral diabetic pharmacotherapy?
Continue all oral hypoglycaemic agents with a sip of water on the morning of surgery to maintain strict normoglycaemia
Withhold metformin and gliclazide on the morning of surgery, but instruct the patient to take his dapagliflozin as scheduled
Withhold dapagliflozin now and alert the anaesthetic and diabetes teams about the missed interval. If surgery proceeds, omit gliclazide and metformin on the day.
Switch all three medications to a high-dose sliding scale regular insulin monotherapy regimen starting the evening before surgery
An adult is tachypnoeic and confused. Simultaneous tests show arterial pH 7.40, PaCO₂ 20 mmHg, bicarbonate 12 mmol/L, sodium 140 mmol/L and chloride 104 mmol/L. Which interpretation best fits?
An isolated respiratory alkalosis with no evidence of a raised anion gap
A raised-anion-gap metabolic acidosis with additional respiratory acidosis
Normal acid–base status because the pH is 7.40
A raised-anion-gap metabolic acidosis with additional respiratory alkalosis
Sections you finish are checked off in the contents.